IVERIC bio, Inc.
IVERIC bio, Inc. (ISEE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ISEE · as of Jun 8, 2026
Key Statistics
Explore IVERIC bio, Inc. Data
isee stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 24 · Buy rate: 37.5%
The ISEE analyst consensus is Hold, based on ratings from 24 Wall Street analysts over the past 3 months. The average 12-month price target is $32.75, representing -18.02% downside from the current price of $39.95.
Competitors & Peers
isee competitorsISEE
ABCM
ALPN
CBAY
CERE
LHCGStock Performance
Full HistoryAbout IVERIC bio, Inc.
IVERIC bio, Inc. is a biopharmaceutical enterprise focused on identifying and advancing innovative therapeutic solutions for eye conditions, with a particular emphasis on age-related and rare inherite…
what is iveric bio, inc. · isee stock overview · iveric bio, inc. company profile · who is iveric bio, inc. ceo · isee NASDAQ · iveric bio, inc. headquarters · iveric bio, inc. business segments
About Stock Overview & Key Data
IVERIC bio, Inc. (ISEE) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 25, 2013. As of the latest trading session, ISEE stock price is $39.95, with a market capitalization of $5.5B. The stock has returned +198.58% over the past 12 months and +98.56% year-to-date.
According to 24 Wall Street analysts, the consensus rating for IVERIC bio, Inc. stock is Hold, with an average 12-month price target of $32.75. In fiscal year 2022, IVERIC bio, Inc. reported revenue of — and net income of -$175.7M. For detailed data — including IVERIC bio, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, IVERIC bio, Inc. (ISEE) stock price is $39.95. The stock is traded on NASDAQ under the ticker symbol ISEE. The 52-week range is $9.39 – $39.99.